S. Hughes

J. Shamash, D. Landau, S. Hughes, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Managing hot flushes in men receiving androgen deprivation therapy for prostate cancer

S. Hughes, Atia Khan, Rachel Lewis, 2014 .

Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.

M. Aapro, S. Hughes, J. Droz, 2017, European urology.

The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people

S. Hughes, P. Ross, F. Martin, 2015, British Journal of Cancer.

Overall survival, disease‐specific survival and local recurrence outcomes in patients with muscle‐invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic review

S. Hughes, R. Nair, M. van Hemelrijck, 2020, BJU international.

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

D. Berney, R. Huddart, T. Powles, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.

T. Sugihara, M. Kattan, F. Saad, 2014, The Lancet. Oncology.

Management of Prostate Cancer

S. Hughes, A. Aggarwal, 2017 .

Advances in advanced prostate cancer – the continuing journey

S. Hughes, H. Payne, S. Crabb, 2016, BJU international.

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for clinically localised high-risk or node-positive prostate cancer: ENZARAD (ANZUP 1303).

M. Stockler, S. Hughes, I. Davis, 2016 .

Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.

Muhammad S. Khan, S. Hughes, D. Josephs, 2019, European Urology.

Managing patients with metastatic prostate cancer: who takes the lead?

N. Clarke, S. Brewster, S. Hughes, 2017 .

Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?

D. Landau, S. Hughes, S. Aylwin, 2012, Clinical endocrinology.

Radical radiotherapy for high-risk prostate cancer in older men.

S. Hughes, H. Payne, 2012, The oncologist.

Assessment of respiratory cycle variability with and without training using a visual guide

J. McClelland, D. Hawkes, J. Blackall, 2008 .

Safety study of induction chemotherapy followed by Synchronous Radiotherapy (RT) and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study (Cohort I): P2-184

J. Shamash, D. Landau, S. Rankin, 2007 .

Prompt diagnosis key in bladder cancer.

S. Hughes, S. Chowdhury, K. Desouza, 2014, The Practitioner.

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.

T. Powles, S. Hughes, M. S. van der Heijden, 2018, European Urology.

Immunotherapy for bladder cancer: rediscovering an old friend

S. Hughes, S. Rudman, S. Chowdhury, 2016, BJU international.